Cytokinetics Inc (NAS:CYTK)
$ 48.5 -0.48 (-0.98%) Market Cap: 5.09 Bil Enterprise Value: 5.28 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 43/100

Cytokinetics Inc GALACTIC-HF Investor/Media Event Transcript

Nov 13, 2020 / 06:00PM GMT
Release Date Price: $16.52 (-5.06%)
Diane Weiser
Cytokinetics, Incorporated - SVP of Corporate Communications & IR

Welcome, everyone, and thanks for joining us on the call today, focused on the primary results of GALACTIC-HF. I'm Diane Weiser, Senior Vice President of Corporate Communications and Investor Relations at Cytokinetics. We have a great program planned for you today.

Before I continue, please note that portions of the following discussion, including our responses to questions, contain statements that relate to future events and performance rather than historical facts and constitute forward-looking statements.

Our actual results might differ materially from those projected in these forward-looking statements. Additional information concerning factors that could cause us -- our actual results to differ materially from those in these forward-looking statements is contained in our SEC filings.

We undertake no obligation to update any forward-looking statements after this call.

So Robert Blum, our President and Chief Executive Officer, will lead us off with an overview of today's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot